July is Cord Blood Awareness Month
Parenthood comes with powerful choices.

Celebrate and save over 40% on newborn stem cell preservation through July 31st. Save Now >
To celebrate Cord Blood Awareness Month 2025 and the healing potential of newborn stem cells, Cord Blood Registry (CBR), the #1 OB/GYN-recommended newborn stem cell preservation company,1 asked families why they chose to bank their baby’s cord blood and cord tissue with us.
More than 600 CBR parents* responded with deeply personal reasons, each rooted in a desire to help safeguard their family’s future. Their answers were as unique as the families themselves, but all shared a common thread: doing everything possible to protect what matters most. This July, we're proud to share their stories.*
When you realize you are about to bring another life into the world, all you want to do is use everything in your power to protect this life and take care of it.
Oksana Y.
CBR momCord blood is a powerful source of stem cells with a proven track record in transplant medicine.2 These remarkable stem cells can be used to treat over 80 conditions,3 including certain cancers, blood disorders, and immune deficiencies. For more than 30 years, cord blood has been used in stem cell transplants to help tens of thousands of people worldwide.2 In fact, over 50,000 stem cell transplants have been performed globally using cord blood from both public donor banks and private family banks.4
It’s a low cost for the peace of mind knowing that we have the cells available should we ever need them.
David J.
CBR dadPreserving cord blood at birth offers a unique opportunity to safeguard a potentially valuable medical resource for the future. By collecting and storing stem cells at birth, we effectively "stop the clock," which helps preserve their unique properties for potential future use.5 Cord blood also offers more flexible genetic matching compared to adult stem cell sources,6 which may be especially important in transplants. Quality collection practices can help maximize the clinical utility of a sample, especially given that having a larger dose of stem cells for a stem cell transplant is associated with improved medical outcomes.7
After extensive online research, choosing CBR was a no-brainer due to the size and scale of their storage facilities as well as customer feedback.
Rachel C.
CBR momSince 1992, families have entrusted CBR to store more than one million cord blood and cord tissue samples.8 As the largest and most experienced family newborn stem cell company in the United States,8 we are proud to be the #1 choice of parents for newborn stem cell preservation.8 CBR has also released more units intended for medical use than any other family bank, with over 750 samples provided to families for transplant medicine and regulated investigational regenerative medicine applications.8
CBR checked all my boxes. Facilities are in an area where possibility of damage to the building is minimal, pricing was very fair, and customer service was exceptional.
Lilla A.
CBR momAdvanced technology and decades of experience are at the heart of newborn stem cell preservation at CBR. In our state-of-the-art lab in Tucson, Arizona, each cord blood sample undergoes processing with the AXP® II platform, which is a functionally closed, automated processing method. Having a functionally closed processing method helps reduce the risk of contamination and automation helps to maintain consistency.9 For added peace of mind, every sample is checked to make sure it meets important quality standards.
I am alive today (and also a mom today) because of the miraculous power of stem cells and I know there is still even more untapped potential.†
Lauren O.
Preserving cord blood means that it is rapidly available which can minimize delays in treatment.10 After processing, the stem cells are cryopreserved in vapor above liquid nitrogen at approximately -196° Celsius to help ensure long-term stability.8 Studies have shown that cryopreservation helps cord blood samples stay usable even after being stored for many years, as long as they’re kept in the right conditions.11
My son received my daughter’s cord blood at Duke in 2018. We believe it helped him gain motor skills he previously did not have.
Tara M.
The CBR® Newborn Possibilities Program® has preserved over 13,0008 newborn stem cell samples by offering free processing and five years of storage to families with certain medical needs. More than 7,500 children8 have taken part in the program, and about 24% of all CBR stem cell units released for medical use have come from it8 — showing how important this program is in making treatments more accessible.
Stem cell research is incredible. Our knowledge of it grows every year. I want to preserve this incredible resource for my family. It could be life-changing.
Amber M.
CBR momBeyond current treatments, cord blood has been evaluated in regenerative medicine for conditions such as hypoplastic left heart syndrome, type 1 diabetes, spinal cord injury, cerebral palsy, and hypoxic neurological injury.10 More than 500 clinical trials have been initiated to study cord blood and cord tissue in regenerative medicine.12 Newborn stem cells know how to find injured cells and tissue and start the healing process, making them an appealing cell source for research.13
The continued research on the powers of cord blood make me believe that this investment is worth its weight in gold.
Shelby H.
Duke University has performed a number of studies evaluating the use of newborn stem cells as a potential treatment for acquired neurological conditions like cerebral palsy and hypoxic ischemic encephalopathy.14 Additionally, individuals with certain pediatric brain injuries may be eligible for off-study infusions of cord blood through Duke’s Expanded Access Protocol.15
CBR provided so much information and answered all of my questions which made it such an easy process. The kit was delivered to my house so quickly and everything was so self-explanatory. It made the collection process easy for my medical team and myself. It was totally stress free.
Natalie B.
CBR momPreserving your baby’s newborn stem cells is a once-in-a-lifetime chance to prepare for life’s unexpected moments. This Cord Blood Awareness Month, enroll with CBR — the trusted leader in newborn stem cell preservation — and take a powerful step toward protecting your family’s future. Know someone expecting? Share this with them and help spread the word about the healing potential of newborn stem cells.
Learn more |
*These quotes depict the families’ personal experiences and are not necessarily representative of others’ experiences and cannot predict outcomes for others. CBR cannot and does not guarantee specific results. Your physician or other healthcare providers should be consulted about your particular situation. Each of these parents completed a survey and in doing so were given the opportunity to enter a giveaway.
†The source of stem cells for this client’s treatment is unknown.
**Referral program applies only to existing CBR clients (“Referring Clients”) referring new clients to CBR (“Referred Clients”). Referring Clients must accept terms of promotion and join CBR before receiving client referral rewards. Referred Client must enroll using referral link provided by Referring Client or mention Referring Client when enrolling over the phone. Discount may not be combined with other offers. Gift card promotion valid June 01, 2016 – December 31, 2025. Full terms and conditions can be found here.
††See Official Rules. U.S. residents over 18 only. Void where prohibited by law. Restrictions apply.
1. Blind survey, Egg Strategy, 10/19, funded by CBR.
2. Zhu X, Tang B, Sun Z. Umbilical cord blood transplantation: Still growing and improving. Stem Cells Transl Med. 2021;10 Suppl 2(Suppl 2):S62-S74. doi:10.1002/sctm.20-0495.
3. Mayani, H., Wagner, J.E. & Broxmeyer, H.E. Cord blood research, banking, and transplantation: achievements, challenges, and perspectives. Bone Marrow Transplant 55, 48–61 (2020). https://doi.org/10.1038/s41409-019-0546-9.
4. Mayani H. Cellular Therapies: Yesterday, Today, and Tomorrow. Stem Cells Dev. 2023;32(7-8):163-169. doi:10.1089/scd.2022.0294.
5. Jang TH, Park SC, Yang JH, et al. Cryopreservation and its clinical applications. Integr Med Res. 2017;6(1):12-18. doi:10.1016/j.imr.2016.12.001.
6. Ballen K. Update on umbilical cord blood transplantation. F1000Res. 2017;6:1556. Published 2017 Aug 24. doi:10.12688/f1000research.11952.1.
7. Scaradavou A, Stevens C, Dobrila L, et al. Cord Blood (CB) Unit Mononuclear Cell (MNC) Dose: Effect on Transplantation Outcome and Relevance to Processing Method and CBU Selection. Blood. 2008;112:1969.
8. Internal data on file.
9. Rosenthal J, Brown HL, Harris DT. Stem cell recovery following implementation of an automated cord blood processing system in a high volume laboratory. Biol Blood Marrow Transplant. 2008;14(2):42s.
10. Kindwall-Keller TL, Ballen KK. Umbilical cord blood: The promise and the uncertainty. Stem Cells Transl Med. 2020;9(10):1153-1162. doi:10.1002/sctm.19-0288.
11. Broxmeyer HE, Luchsinger LL, Weinberg RS, et al. Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood [published online ahead of print, 2023 Oct 26]. Cell Rep Med. 2023;101259. doi:10.1016/j.xcrm.2023.101259.
12. U.S. National Library of Medicine. ClinicalTrials.gov. Accessed October 2024. https://clinicaltrials.gov/.
13. Torre P, Flores AI. Current Status and Future Prospects of Perinatal Stem Cells. Genes (Basel). 2020 Dec 23;12(1):6. doi: 10.3390/genes12010006. PMID: 33374593; PMCID: PMC7822425.
14. McLaughlin C, West T, Hollowell R, et al. Expanded Access Protocol of Umbilical Cord Blood Infusion for Children with Neurological Conditions: An Update. Stem Cells Transl Med. 2021;10(S1):S7-S8. doi:10.1002/sct3.13016.
15. Expanded Access Protocol: Umbilical Cord Blood Infusions for Children With Brain Injuries. https://clinicaltrials.gov/study/NCT03327467. Accessed May 28, 2025.
SHARE